TNF-alpha transgenic and knockout models of CNS inflammation and degeneration (Q41355429)

29 September 2017

1 reference

title

TNF-alpha transgenic and knockout models of CNS inflammation and degeneration (English)

1 reference

29 September 2017

4

1 reference

29 September 2017

5

1 reference

29 September 2017

6

1 reference

29 September 2017

2

Akassoglou K

1 reference

29 September 2017

Probert L

1

1 reference

29 September 2017

Kassiotis G

series ordinal

3

1 reference

29 September 2017

publication date

1 February 1997

1 reference

Journal of Neuroimmunology

29 September 2017

published in

1 reference

29 September 2017

volume

72

1 reference

29 September 2017

issue

2

1 reference

29 September 2017

page(s)

137-141

1 reference

Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Cytokines up-regulate Ia expression in organotypic cultures of central nervous system tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

CNS antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Production and function of monocyte chemoattractant protein-1 and other β-chemokines in murine glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Astrocytes induce blood–brain barrier properties in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Effects of Interleukin-1 and Tumor Necrosis Factor-α on Astrocytes, Microglia, Oligodendrocytes, and Glial Precursors in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Blood-brain barrier to albumin in embryonic new born and adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune re

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Tumour necrosis factors in immune regulation: everything that's interesting is...new!

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Inflammation in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Multiple sclerosis: TNF revisited, with promise

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Chemokines in immune-mediated inflammation of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-alpha, interleukin-1 beta, and interferon-gamma in astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

Two tumour necrosis factor receptors: structure and function.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900184-1

7 January 2021

10.1016/S0165-5728(96)00184-1

Identifiers

DOI

1 reference

29 September 2017

1 reference